Insider Filing Note: The Insider, Frank Debenedittis Unloaded 7,040 Shares of Aceto Corporation (NASDAQ:ACET)

November 30, 2016 - By whatsonthorold

Insider Filing Note: The Insider, Frank Debenedittis Unloaded 7,040 Shares of Aceto Corporation (NASDAQ:ACET)

Frank Debenedittis Insider Sell

The Sr. Vice President of Aceto Corp, Frank Debenedittis recently got around $142,383 U.S. Dollars for 7,040 shares in the Aceto Corp company at an about $20.2 for every share. The sale was revealed in a SEC Form 4 on November 29, 2016. Frank Debenedittis right now owns 77,625 shares or 0.26% of the company’s total market capitalization.

Insitutional Activity: The institutional sentiment increased to 1.22 in Q2 2016. Its up 0.36, from 0.86 in 2016Q1. The ratio improved, as 16 funds sold all Aceto Corporation shares owned while 49 reduced positions. 11 funds bought stakes while 45 increased positions. They now own 23.91 million shares or 7.56% less from 25.86 million shares in 2016Q1.

Deutsche Bank Ag has invested 0% of its portfolio in Aceto Corporation (NASDAQ:ACET). Ls Inv Limited Liability Co holds 0% of its portfolio in Aceto Corporation (NASDAQ:ACET) for 1,184 shares. Advisory Svcs Net holds 0% or 121 shares in its portfolio. Prudential Fincl has 71,771 shares for 0% of their US portfolio. Blackrock Mngmt Llc holds 0% or 127,141 shares in its portfolio. Manufacturers Life Communications The has 19,930 shares for 0% of their US portfolio. Signaturefd Ltd Co reported 315 shares or 0% of all its holdings. Credit Suisse Ag holds 0% of its portfolio in Aceto Corporation (NASDAQ:ACET) for 50,733 shares. Voya Invest Mngmt Limited Com has 0% invested in the company for 12,357 shares. Fisher Asset Management Llc accumulated 167,853 shares or 0.01% of the stock. Morgan Stanley holds 0% or 407,599 shares in its portfolio. Blackrock Gp Limited reported 29,161 shares or 0% of all its holdings. Meeder Asset Inc accumulated 3,314 shares or 0.01% of the stock. Envestnet Asset last reported 0% of its portfolio in the stock. Geode Cap Management Ltd Liability has 0% invested in the company for 207,946 shares.

Insider Transactions: Since May 31, 2016, the stock had 0 insider purchases, and 32 selling transactions for $3.34 million net activity. $2,961 worth of shares were sold by ROTH DOUGLAS A on Tuesday, September 6. DEBENEDITTIS FRANK sold $76,426 worth of Aceto Corporation (NASDAQ:ACET) on Thursday, July 7. GUCCIONE SALVATORE J SR sold $368,615 worth of stock or 18,600 shares. $100,203 worth of Aceto Corporation (NASDAQ:ACET) was sold by Shackley Nicolas I. The insider NOETZLI HANS C sold 6,000 shares worth $109,906. $219,486 worth of Aceto Corporation (NASDAQ:ACET) was sold by EILENDER ALBERT L on Tuesday, May 31. $97,100 worth of Aceto Corporation (NASDAQ:ACET) was sold by BRITTON WILLIAM N on Tuesday, June 7.

About 212,724 shares traded hands. Aceto Corporation (NASDAQ:ACET) has declined 13.99% since April 27, 2016 and is downtrending. It has underperformed by 19.21% the S&P500.

Aceto Corporation is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The company has a market cap of $622.30 million. The Company’s business is organized along product lines into three divisions: Human Health, Pharmaceutical Ingredients and Performance Chemicals. It has a 20.3 P/E ratio. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries.

According to Zacks Investment Research, “Aceto Corporation markets, sells and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products and specialty chemicals. The company’s operating segment consists of Human Health, Pharmaceutical Ingredients and Performance Chemicals. Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements. It markets and distributes its generic prescription and over the counter pharmaceutical products. Pharmaceutical Ingredients segment offers active pharmaceutical ingredients and pharmaceutical intermediates. Performance Chemicals segment provides specialty chemicals. It serves chemical, agricultural, human health and pharmaceutical industries. The company operates primarily in United States, Europe, and Asia. Aceto Corporation and is headquartered in Port Washington, New York.”

Analysts await Aceto Corporation (NASDAQ:ACET) to report earnings on February, 2. They expect $0.35 EPS, down 2.78% or $0.01 from last year’s $0.36 per share. ACET’s profit will be $10.65 million for 14.61 P/E if the $0.35 EPS becomes a reality. After $0.28 actual EPS reported by Aceto Corporation for the previous quarter, Wall Street now forecasts 25.00% EPS growth.

More notable recent Aceto Corporation (NASDAQ:ACET) news were published by: Fool.com which released: “Why Shares of Aceto Corporation Plunged 23% Today” on August 26, 2016, also Streetinsider.com with their article: “ACETO Corp (ACET) Announces $412M Acquisition of Certain Assets from Citron ..” published on November 03, 2016, Globenewswire.com published: “ACETO Corporation Schedules Fourth Quarter & Fiscal 2016 Financial Results ..” on August 12, 2016. More interesting news about Aceto Corporation (NASDAQ:ACET) were released by: Globenewswire.com and their article: “ACETO Corporation Announces $125 Million Convertible Notes Offering” published on November 09, 2015 as well as Quotes.Wsj.com‘s news article titled: “News Aceto Corp.ACET” with publication date: February 13, 2011.

ACET Company Profile

Aceto Corporation (Aceto), incorporated on June 13, 1947, is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company’s business is organized along product lines into three divisions: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, the Company distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. The Firm has presence in China, Germany, France, The Netherlands, Singapore, India, Hong Kong, Philippines, the United Kingdom and the United States.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>